Do analysts rate FLGC or LFWD?

Lifeward has a consensus price target of $10.00, suggesting a potential upside of 70.94%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lifeward 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger valuation and earnings, FLGC or LFWD?

Flora Growth has higher revenue and earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Flora Growth $57.61M 0.09 -$15.91M -$32.49 N/A Lifeward $21.82M 0.76 -$19.91M -$16.82 N/A

Is FLGC or LFWD more profitable?

Flora Growth has a net margin of -32.03% compared to Lifeward's net margin of -141.28%. Flora Growth's return on equity of -64.02% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Flora Growth -32.03% -64.02% -34.46% Lifeward -141.28% -235.86% -81.72%

Do analysts recommend FLGC or FEMY?

Femasys has a consensus price target of $50.00, indicating a potential upside of 2,339.02%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has higher earnings and valuation, FLGC or FEMY?

Flora Growth has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Flora Growth $57.61M 0.09 -$15.91M -$32.49 N/A Femasys $2.29M 7.50 -$18.63M -$3.53 N/A

Is FLGC or FEMY more profitable?

Flora Growth has a net margin of -32.03% compared to Femasys' net margin of -534.36%. Flora Growth's return on equity of -64.02% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Flora Growth -32.03% -64.02% -34.46% Femasys -534.36% -225.97% -74.68%

Do analysts recommend FLGC or ICU?

SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 70.58%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts plainly believe SeaStar Medical is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend FLGC or MODD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend FLGC or CUPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, FLGC or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Flora Growth. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Flora Growth $57.61M 0.09 -$15.91M -$32.49 N/A Cuprina Holdings (Cayman) $49.89K 339.71 -$3.63M N/A N/A

Flora Growth (FLGC) Competitors

$4.86 +0.02 (+0.41%)

As of 10/2/2026

Compare

FLGC vs. LFWD, FEMY, ICU, MODD, and CUPR

Should you buy Flora Growth stock or one of its competitors? Flora Growth's main competitors and comparable companies include Lifeward (LFWD), Femasys (FEMY), SeaStar Medical (ICU), Modular Medical (MODD), and Cuprina Holdings (Cayman) (CUPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Flora Growth compare to Lifeward?

Flora Growth (NASDAQ:FLGC) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

In the previous week, Lifeward had 2 more articles in the media than Flora Growth. MarketBeat recorded 2 mentions for Lifeward and 0 mentions for Flora Growth. Flora Growth's average media sentiment score of 0.00 equaled Lifeward'saverage media sentiment score.

Company	Overall Sentiment
Flora Growth	Neutral
Lifeward	Neutral

Flora Growth has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market.

36.0% of Flora Growth shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 2.3% of Flora Growth shares are held by insiders. Comparatively, 1.5% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Lifeward has a consensus price target of $10.00, suggesting a potential upside of 70.94%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Flora Growth has higher revenue and earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
Lifeward	$21.82M	0.76	-$19.91M	-$16.82	N/A

Flora Growth has a net margin of -32.03% compared to Lifeward's net margin of -141.28%. Flora Growth's return on equity of -64.02% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
Lifeward	-141.28%	-235.86%	-81.72%

Summary

Flora Growth beats Lifeward on 9 of the 15 factors compared between the two stocks.

How does Flora Growth compare to Femasys?

Flora Growth (NASDAQ:FLGC) and Femasys (NASDAQ:FEMY) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

Femasys has a consensus price target of $50.00, indicating a potential upside of 2,339.02%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Flora Growth has a net margin of -32.03% compared to Femasys' net margin of -534.36%. Flora Growth's return on equity of -64.02% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
Femasys	-534.36%	-225.97%	-74.68%

In the previous week, Femasys had 1 more articles in the media than Flora Growth. MarketBeat recorded 1 mentions for Femasys and 0 mentions for Flora Growth. Femasys' average media sentiment score of 1.08 beat Flora Growth's score of 0.00 indicating that Femasys is being referred to more favorably in the news media.

Company	Overall Sentiment
Flora Growth	Neutral
Femasys	Positive

Flora Growth has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
Femasys	$2.29M	7.50	-$18.63M	-$3.53	N/A

Flora Growth has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market. Comparatively, Femasys has a beta of -2.16, meaning that its stock price is 316% less volatile than the broader market.

36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 2.3% of Flora Growth shares are owned by insiders. Comparatively, 7.8% of Femasys shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Femasys beats Flora Growth on 9 of the 16 factors compared between the two stocks.

How does Flora Growth compare to SeaStar Medical?

Flora Growth (NASDAQ:FLGC) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Flora Growth has a net margin of -32.03% compared to SeaStar Medical's net margin of -795.51%. Flora Growth's return on equity of -64.02% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
SeaStar Medical	-795.51%	-162.75%	-109.89%

SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 70.58%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts plainly believe SeaStar Medical is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Flora Growth has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.09, suggesting that its share price is 209% less volatile than the broader market.

In the previous week, SeaStar Medical had 5 more articles in the media than Flora Growth. MarketBeat recorded 5 mentions for SeaStar Medical and 0 mentions for Flora Growth. SeaStar Medical's average media sentiment score of 0.28 beat Flora Growth's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Flora Growth	Neutral
SeaStar Medical	Neutral

36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 2.3% of Flora Growth shares are owned by company insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

SeaStar Medical has lower revenue, but higher earnings than Flora Growth. SeaStar Medical is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
SeaStar Medical	$1.23M	16.82	-$12.15M	-$3.91	N/A

Summary

Flora Growth and SeaStar Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Flora Growth compare to Modular Medical?

Flora Growth (NASDAQ:FLGC) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

36.0% of Flora Growth shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 2.3% of Flora Growth shares are held by insiders. Comparatively, 7.1% of Modular Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Modular Medical has a net margin of 0.00% compared to Flora Growth's net margin of -32.03%. Flora Growth's return on equity of -64.02% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
Modular Medical	N/A	-292.14%	-222.79%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Flora Growth has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

Flora Growth has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market.

In the previous week, Flora Growth's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.

Company	Overall Sentiment
Flora Growth	Neutral
Modular Medical	Neutral

Summary

Flora Growth beats Modular Medical on 7 of the 10 factors compared between the two stocks.

How does Flora Growth compare to Cuprina Holdings (Cayman)?

Flora Growth (NASDAQ:FLGC) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

In the previous week, Cuprina Holdings (Cayman) had 4 more articles in the media than Flora Growth. MarketBeat recorded 4 mentions for Cuprina Holdings (Cayman) and 0 mentions for Flora Growth. Flora Growth's average media sentiment score of 0.00 beat Cuprina Holdings (Cayman)'s score of -0.15 indicating that Flora Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Flora Growth	Neutral
Cuprina Holdings (Cayman)	Neutral

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Flora Growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
Cuprina Holdings (Cayman)	$49.89K	339.71	-$3.63M	N/A	N/A

36.0% of Flora Growth shares are held by institutional investors. 2.3% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Flora Growth has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Flora Growth's net margin of -32.03%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Flora Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

Summary

Cuprina Holdings (Cayman) beats Flora Growth on 6 of the 11 factors compared between the two stocks.

Get Flora Growth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FLGC vs. The Competition

Export

Metric	Flora Growth	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.08M	$5.45B	$7.14B	$13.18B
Dividend Yield	N/A	1.80%	2.53%	16.78%
P/E Ratio	-0.15	24.90	275.97	26.04
Price / Sales	0.09	84.87	669.23	109.59
Price / Cash	N/A	32.43	77.60	51.75
Price / Book	0.40	5.73	10.93	6.31
Net Income	-$15.91M	$152.68M	$3.51B	$362.16M
7 Day Performance	19.41%	-1.71%	-2.00%	-1.66%
1 Month Performance	-4.33%	-4.81%	-6.15%	-4.50%
1 Year Performance	-74.38%	1.08%	7.44%	2.06%

Flora Growth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FLGC Flora Growth	0.0836 of 5 stars	$4.86 +0.4%	N/A	-73.2%	$5.08M	$57.61M	N/A	280
LFWD Lifeward	1.9392 of 5 stars	$6.85 -0.9%	$10.00 +46.0%	-37.2%	$19.39M	$22.03M	N/A	81	News Coverage
FEMY Femasys	3.1189 of 5 stars	$2.17 +3.6%	$50.00 +2,209.5%	-75.3%	$18.14M	$2.29M	N/A	54	News Coverage Positive News Analyst Downgrade Gap Up
ICU SeaStar Medical	2.8245 of 5 stars	$4.05 +13.8%	$8.00 +97.5%	-31.5%	$17.55M	$1.23M	N/A	2	News Coverage
MODD Modular Medical	0.2126 of 5 stars	$1.94 -0.6%	N/A	-90.2%	$15.81M	N/A	N/A	51

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FLGC) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Flora Growth (FLGC) Competitors

FLGC vs. LFWD, FEMY, ICU, MODD, and CUPR

How does Flora Growth compare to Lifeward?

Summary

How does Flora Growth compare to Femasys?

Summary

How does Flora Growth compare to SeaStar Medical?

Summary

How does Flora Growth compare to Modular Medical?

Summary

How does Flora Growth compare to Cuprina Holdings (Cayman)?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGC vs. The Competition

Flora Growth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Flora Growth (FLGC) Competitors

FLGC vs. LFWD, FEMY, ICU, MODD, and CUPR

How does Flora Growth compare to Lifeward?

Does the media prefer FLGC or LFWD?

Which has more volatility & risk, FLGC or LFWD?

Do insiders and institutionals hold more shares of FLGC or LFWD?

Do analysts rate FLGC or LFWD?

Which has stronger valuation and earnings, FLGC or LFWD?

Is FLGC or LFWD more profitable?

Summary

How does Flora Growth compare to Femasys?

Do analysts recommend FLGC or FEMY?

Is FLGC or FEMY more profitable?

Does the media prefer FLGC or FEMY?

Which has higher earnings and valuation, FLGC or FEMY?

Which has more volatility and risk, FLGC or FEMY?

Do institutionals and insiders have more ownership in FLGC or FEMY?

Summary

How does Flora Growth compare to SeaStar Medical?

Is FLGC or ICU more profitable?

Do analysts recommend FLGC or ICU?

Which has more risk & volatility, FLGC or ICU?

Does the media refer more to FLGC or ICU?

Do institutionals & insiders have more ownership in FLGC or ICU?

Which has stronger earnings and valuation, FLGC or ICU?

Summary

How does Flora Growth compare to Modular Medical?

Do insiders & institutionals have more ownership in FLGC or MODD?

Is FLGC or MODD more profitable?

Do analysts recommend FLGC or MODD?

Which has preferable valuation & earnings, FLGC or MODD?

Which has more risk and volatility, FLGC or MODD?

Does the media refer more to FLGC or MODD?

Summary

How does Flora Growth compare to Cuprina Holdings (Cayman)?

Does the media favor FLGC or CUPR?

Which has stronger valuation & earnings, FLGC or CUPR?

Do institutionals & insiders hold more shares of FLGC or CUPR?

Which has more volatility & risk, FLGC or CUPR?

Do analysts recommend FLGC or CUPR?

Is FLGC or CUPR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGC vs. The Competition

Flora Growth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools